Study period | ||||||
---|---|---|---|---|---|---|
Enrolment | Baseline | Treatment phase | Follow-up phase | |||
Timepoint | − 1 week | 0 week | 4 weeks | 8 weeks | 12 weeks | 24 weeks |
Enrolment | ||||||
Eligibility screen | × | |||||
Informed consent | × | |||||
Medical history | × | |||||
Merger disease | × | |||||
Randomization | × | |||||
Interventions | ||||||
Treatment group | × | × | × | |||
Control group | × | × | × | |||
Assessments | ||||||
MMSE | × | × | × | × | × | |
MOCA | × | × | × | × | × | |
BI | × | × | × | × | × | |
Safety evaluation | × | × | ||||
Adverse events | × | × | × | × | × |